Gene · 64344
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Time-Resolved Network Entropy Analysis Identifies a CTNND1-VAV3 Subnetwork in Gefitinib-Resistant NSCLC. | Int J Mol Sci | 2026 | 42794834 | PubTator, text mining | PubMed |
| Mitochondrial Transplantation Rejuvenates Aging Heart by Restoring Mitophagy Flux via the HIF-3α-BNIP3 Axis. | Aging Cell | 2026 | 42775695 | PubTator, text mining | PubMed |
| HIF-2α Depletion and HIF-1α Overexpression in Vulnerable Brain Regions Distinguish Alzheimer's Disease with Cerebral Amyloid Angiopathy. | Int J Mol Sci | 2026 | 42737681 | PubTator, text mining | PubMed |
| HIFs: The central drivers of tumors and their role as molecular switches in targeted therapy? | Acta Pharm Sin B | 2026 | 42592210 | PubTator, text mining | PubMed |
| Post-Treatment Persistent Erythrocytosis in Patients with Hodgkin Lymphoma: Molecular Mechanisms Underlying the Pathogenesis of Erythrocytosis. | Cancers (Basel) | 2026 | 42588719 | PubTator, text mining | PubMed |
| Reduced Circulating HIF-1α, HIF-2α, HIF-3α, and VHL Levels in Patients With Pulmonary Arterial Hypertension. | Pulm Circ | 2026 | 42254878 | PubTator, text mining | PubMed |
| Regulatory mechanisms of hypoxia-inducible factors on ferroptosis in ischemic stroke. | PeerJ | 2026 | 42254662 | PubTator, text mining | PubMed |
| Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways. | Oncology | 2026 | 41945479 | PubTator, text mining | PubMed |
| An Activity-Dependent NEPAS-PTX3 Axis Links Neurovascular and Myelin Deficits to Cognitive Impairment. | Adv Sci (Weinh) | 2026 | 41944308 | PubTator, text mining | PubMed |
| Research progress of mesenchymal stem cells/stromal cells and their derivatives against cell senescence in the treatment of osteoarthritis. | Ann Med | 2026 | 41919394 | PubTator, text mining | PubMed |
| Implication of Epigenetic Alterations of ZEB1 in Colorectal Cancer (CRC) Pathogenesis and Therapy Development. | Curr Issues Mol Biol | 2026 | 41899428 | PubTator, text mining | PubMed |
| Deciphering the cardiac neuron landscape in heart failure patients. | PLoS Comput Biol | 2026 | 41860822 | PubTator, text mining | PubMed |
| Current research on the HIF-2α-EPO-Hb axis in hypoxic environments: from molecular mechanisms to clinical. | Front Med (Lausanne) | 2026 | 41810235 | PubTator, text mining | PubMed |
| HIF1α reinforces PPARγ-dependent metabolic rechanneling to support lipid accumulation in adipocytes. | Front Mol Med | 2026 | 41809996 | PubTator, text mining | PubMed |
| HIF3A-mediated aberrant activation of TXNIP promotes Alzheimer's disease progression. | Sci Rep | 2026 | 41807716 | PubTator, text mining | PubMed |
| Hypoxia-inducible factors in the immunometabolism of metabolic dysfunction-associated steatotic liver disease (MASLD): molecular mechanisms and therapeutic implications. | Front Physiol | 2026 | 41797847 | PubTator, text mining | PubMed |
| The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption? | Transl Oncol | 2026 | 41764979 | PubTator, text mining | PubMed |
| Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence. | Int J Mol Sci | 2026 | 41752200 | PubTator, text mining | PubMed |
| Can Cancer Cell Line In Vitro Radioembolization Model Help to Understand How Beta Radiation Affects Liver Tumor and Improve Treatment Results? | Int J Mol Sci | 2026 | 41751824 | PubTator, text mining | PubMed |
| Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects. | Antioxidants (Basel) | 2026 | 41750534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64344/papers